Transcatheter Valve-in-Valve and Iatrogenic ASD Closure for Tricuspid Thrombosis in Heparin-Induced Thrombocytopenia

Key Points

• The research investigates treatment options for tricuspid thrombosis in patients with heparin-induced thrombocytopenia.
• Utilized transcatheter valve-in-valve (TTViV) approach
• Included patients at high surgical risk due to HIT
• Assessed the effectiveness of Iatrogenic ASD closure
• Demonstrated TTViV as an effective treatment option
• Highlighted improved outcomes for high-surgical risk patients
• Addressed early valve thrombosis risk